B. del Bravo

Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women.

A. Gadducci, M. Ferdeghini, A. Genazzani, 1996, Gynecologic oncology.

Prevalence and incidence of external genital warts in a sample of Italian general female population

L. Mariani, A. Amorosi, B. Suligoi, 2017, BMC Infectious Diseases.

Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma.

A. Gadducci, V. Facchini, B. del Bravo, 1994, Gynecologic oncology.

Adjuvant treatment of early stage ovarian carcinoma.

A. Gadducci, P. Fioretti, M. D'amico, 1990, Clinical and experimental obstetrics & gynecology.

Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status.

A. Gadducci, V. Facchini, P. Fioretti, 1993, Gynecologic oncology.

The topical administration of steroids in the treatment of typical vulvar dystrophies.

A. Gadducci, V. Facchini, P. Fioretti, 1989, Clinical and experimental obstetrics & gynecology.

The potential of primary cytoreductive surgery in patients with FIGO stages III and IV ovarian carcinoma.

A. Gadducci, P. Fioretti, B. del Bravo, 1990, European journal of gynaecological oncology.

Pretreatment plasma levels of fibrinopeptide‐A (FPA), D‐dimer (DD), and von Willebrand Factor (vWF) in patients with operable cervical cancer: Influence of surgical‐pathological stage, tumor size, histologic type, and lymph node status

A. Gadducci, V. Facchini, P. Fioretti, 1994 .